IMMUNOLOGICAL DIFFERENCES BETWEEN PSA PATIENTS WHO ARE TUMOR NECROSIS FACTOR INHIBITOR-NAIVE AND WHO HAVE INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR INHIBITORS

Siebert S, Coates L, Schett G, Raychaudhuri SP, Chen W, Gao S, Chakravarty SD, Shawi M, Lavie F, Theander E, Neuhold M, Kollmeier A, Xu XL, Rahman P, Mease PJ, Deodhar A (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 254-255

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

DOI: 10.1136/annrheumdis-2022-eular.892

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

University of Oxford GB United Kingdom (GB) University of Glasgow GB United Kingdom (GB) University of California Davis (UCDAVIS) US United States (USA) (US) Janssen Pharmaceutica NV BE Belgium (BE) Oregon Health and Science University (OSHU) US United States (USA) (US) Janssen Global Services, LLC US United States (USA) (US) Johnson & Johnson Services, Inc. US United States (USA) (US) Janssen-Cilag France FR France (FR) Memorial University of Newfoundland (MUN) CA Canada (CA) Swedish Medical Center US United States (USA) (US)

How to cite

APA:

Siebert, S., Coates, L., Schett, G., Raychaudhuri, S.P., Chen, W., Gao, S.,... Deodhar, A. (2022). IMMUNOLOGICAL DIFFERENCES BETWEEN PSA PATIENTS WHO ARE TUMOR NECROSIS FACTOR INHIBITOR-NAIVE AND WHO HAVE INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR INHIBITORS. In ANNALS OF THE RHEUMATIC DISEASES (pp. 254-255). LONDON: BMJ PUBLISHING GROUP.

MLA:

Siebert, S., et al. "IMMUNOLOGICAL DIFFERENCES BETWEEN PSA PATIENTS WHO ARE TUMOR NECROSIS FACTOR INHIBITOR-NAIVE AND WHO HAVE INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR INHIBITORS." Proceedings of the ANNALS OF THE RHEUMATIC DISEASES LONDON: BMJ PUBLISHING GROUP, 2022. 254-255.

BibTeX: Download